SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-248505
Filing Date
2018-08-14
Accepted
2018-08-14 16:26:22
Documents
32
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d587784d10q.htm 10-Q 207533
2 EX-3.1 d587784dex31.htm EX-3.1 300924
3 EX-31.1 d587784dex311.htm EX-31.1 6627
4 EX-31.2 d587784dex312.htm EX-31.2 6604
5 EX-32.1 d587784dex321.htm EX-32.1 5107
  Complete submission text file 0001193125-18-248505.txt   1627482

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT oxgn-20180630.xml EX-101.INS 189128
7 XBRL TAXONOMY EXTENSION SCHEMA oxgn-20180630.xsd EX-101.SCH 19426
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE oxgn-20180630_cal.xml EX-101.CAL 21562
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE oxgn-20180630_def.xml EX-101.DEF 33139
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE oxgn-20180630_lab.xml EX-101.LAB 165559
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE oxgn-20180630_pre.xml EX-101.PRE 104097
Mailing Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080 650-635-7000
MATEON THERAPEUTICS INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21990 | Film No.: 181017970
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1